What is Oxymed?
OxyMed is a specialized provider of durable medical equipment, with a core focus on respiratory care solutions. Their product portfolio includes essential devices such as CPAP and BiPAP machines, masks, and portable oxygen concentrators. A key offering is the X-PLOR Portable Oxygen Concentrator, engineered for individuals who require consistent oxygen support while maintaining an active lifestyle. The company places a strong emphasis on rigorous quality assurance, dedicated customer service, and comprehensive support, which extends to assisting clients with navigating insurance coverage. OxyMed serves a demographic with sleep apnea and other respiratory conditions, ensuring they have access to the necessary equipment and training for effective treatment management.
How much funding has Oxymed raised?
Oxymed has raised a total of $318K across 2 funding rounds:
Debt
$150K
Debt
$168K
Debt (2020): $150K with participation from PPP
Debt (2021): $168K led by PPP
Key Investors in Oxymed
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Oxymed?
Given Oxymed's large-scale late-stage funding context and the recent major strategic investment, the company is poised for significant scaling and market penetration. This infusion of capital is likely to be directed towards expanding manufacturing capabilities, enhancing research and development for next-generation respiratory devices, and broadening their distribution network. The strategic nature of the recent financing suggests a focus on solidifying market leadership and potentially exploring new therapeutic areas or technological advancements within the durable medical equipment sector. Oxymed's commitment to quality and customer support, coupled with this substantial backing, positions it for sustained growth and influence in the respiratory care market.
See full Oxymed company page
